1-5 of 5
David Delgado
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1, Dose-Escalation Study of Gilteritinib Combined with Chemotherapy in Patients Aged 6 Months to <21 Years with FLT3 Internal Tandem Duplication-Positive Relapsed or Refractory AML

Philip Connor, Linyi Fan, Stanley Gill, Jason E. Hill, Nisha Philipose, David Delgado, Ramon V. Tiu, Dirk Reinhardt
Journal: Blood
Blood (2021) 138 (Supplement 1): 2315.
https://doi.org/10.1182/blood-2021-147862
Published: 2021
Journal Articles

BMT CTN Protocol 1506: A Phase 3 Trial of Gilteritinib As Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with FLT3- ITD + AML

Mark J. Levis, MD, Mehdi Hamadani, MD, Brent R. Logan, Matt Rosales, David Delgado, Erkut Bahceci, Steven Devine, MD, Mary M. Horowitz, Yi-Bin Chen
Journal: Blood
Blood (2019) 134 (Supplement_1): 4602.
https://doi.org/10.1182/blood-2019-124322
Published: 2019
Journal Articles

Activation of T and NK Cells Following Lenalidomide Therapy in Patients with Follicular Lymphoma.

Seema Rawal, PhD, Nathan Fowler, MD, Min Zhang, Ph.D., Zhiqiang Wang, Ph.D., Tariq Muzzafar, MBBS, Nusrat Harun, MS, Veerabhadran Baladandayuthapani, Ph.D., Rakesh Sharma, Ph.D, David Delgado, Michael Wallace, MD, Carla Heise, PhD, Linda Catherine Lacerte, RN, Felipe Samaniego, M.D., R Eric Davis, M.D, Sattva S. Neelapu, MD
Journal: Blood
Blood (2012) 120 (21): 2766.
https://doi.org/10.1182/blood.V120.21.2766.2766
Published: 2012
Journal Articles

Cross-Talk Between Tumor B Cells, Follicular Dendritic Cells, and Follicular Helper T Cells: Implications for Follicular Lymphoma Pathogenesis and Therapy,

Shibichakravarthy Kannan, PhD, Fuliang Chu, PhD, Seema Rawal, PhD, Myriam Foglietta, MD, David Delgado, Sattva S. Neelapu, MD
Journal: Blood
Blood (2011) 118 (21): 3696.
https://doi.org/10.1182/blood.V118.21.3696.3696
Published: 2011
Journal Articles

CD4 + Foxp3 + Regulatory T Cells Persist in High Numbers in Peripheral Blood after Induction of Clinical Remission with Standard Chemotherapy and Suppress Tumor-Specific Effector T Cells in Patients with Follicular Lymphoma

Myriam Foglietta, MD, David Delgado, Durgha Nattamai, Larry W Kwak, MD, PhD, Sattva Neelapu, MD
Journal: Blood
Blood (2008) 112 (11): 3778.
https://doi.org/10.1182/blood.V112.11.3778.3778
Published: 2008